Two recombinant tissue factor reagents compared to conventional thromboplastins for determination of international normalised ratio: A thirty-three-laboratory collaborative study

Thrombosis and Haemostasis

Volumn 76, Issue 3, 1996, Pages 372-376

  Kitchen, S ^a   Jennings, I ^a   Woods, T A L ^a   Walker, I D ^b   Preston, F E ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT PROTEIN; RECOMBINANT THROMBOPLASTIN; THROMBOPLASTIN; WARFARIN;

ARTICLE; BLOOD CLOTTING; CLINICAL PRACTICE; CONTROLLED STUDY; FREEZE DRYING; HUMAN; LABORATORY TEST; PLASMA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTHROMBIN TIME;

EID: 0029827064     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650586     Document Type: Article

References (16)

1. Loeliger EA, van den Besselaar AMHP, Broekmans AW. Intensity of oral anticoagulation in patients monitored with various thromboplastins. N E J Med 1983; 308: 1228-9.
2. Denson KWE. Thromboplastin - sensitivity, precision and other characteristics. Clin Lab Haem 1988; 10: 315-28.
3. Quick A. The prothrombin in hemophilia and obstructive jaundice. J Biol Chem 1935; 109: 73-4.
4. Rehemtulla A, Pepe M, Edgington TS. High level expression of recombinant human tissue factor in Chinese hamster ovary cells as a human thromboplastin. Thromb Haemosl 1991; 65: 521-7.
5. Sakai T, Kisiel W. Formation of tissue factor activity following incubation of recombinant human tissue factor apoprotein with plasma lipoproteins. Thrombosis Res 1990; 60: 213-22.
6. Hawkins P, Tejidor LP, Estevez R, Johnson K, Murza B, Maynard J, Lowrey D, Thorn R. Gaur P. Prothrombin time reagents prepared from recombinant human tissue factor produced in E. coli. Thromb Haemost 1991; 65: 1215.
7. Tripodi A, Chantarangkul, Bragu M. Poller L. ten Gate JW, Van der Besselaar AMHP, Mannucci PM. Results of a multicenter study assessing the status of standardisation of a recombinant thromboplastin for the control of oral anticoagulant therapy. Thromb Haemost 1994; 72: 261-7.
8. Bader R, Mannucci PM, Tripodi A, Hirsh J, Keller F, Solleder EM, Hawkins P, Peng M, Pelzer H, Teijidor LM, Ramirez IF, Kolde HJ. Multicentric evaluation of a new PT reagent based on recombinant human tissue factor and synthetic phospholipids. Thromb Haemost 1994; 71: 292-9.
9. Roussi J, Drouet L, Samama M, Sié P. French multicentric evaluation of Recombinant Tissue Factor (Recombiplastin) for determination of Prothrombin Time. Thromb Haemost 1994; 72: 698-704.
10. Kitchen S, Walker ID, Woods TAL, Preston FE. Thromboplastin related differences in the determination of International Normalised Ratio: A cause for concern? Thromb Haemost 1994; 72: 426-9.
11. Loeliger EA. van den Besselaar AMHP, Lewis SM. Reliability and clinical impact for the normalisation of the prothrombin times on oral anticoagulant control. Thromb Haemost 1985; 53: 148-54.
12. Poller L, Taberner DA, Thompson JM, Morris J, Mibasham RS, Shinton NK. Effect of the choice of WHO International Reference Preparation for thromboplastin on INR. J Clin Path 1993; 46: 64-6
13. van den Besselaar AMHP. Multicentre study of replacement of the international reference preparation for thromboplastin. rabbit, plain. Thromb Haemost 1993; 70: 794-9.
14. WHO Expert Committee on Biological Standardisation. Thirty-third report. WHO Technical Report Series 1983; 687: 81-105.
15. Tripodi A, Chantarangkul V, Akawat B, Clerici M, Mannucci PM. A partial factor V deficiency in anticoagulated lyophilised plasmas has been identified as a cause of the international normalised ratio discrepancy in the external quality assessment scheme. Thromb Res 1995; 78: 283-92.
16. van den Besselaar AMHP, Bertina RM. Multi-center calibration of the secondary reference material for thromboplastin, Rabbit, Plain, coded CRM 149R. Thromb Haemost 1991; 65: 263-7.